These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6217184)

  • 1. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on 6059-S in children (author's transl)].
    Yanagisawa K; Ide K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1981 May; 34(5):757-63. PubMed ID: 6457174
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of moxalactam.
    Livingston WK; Elliott AM; Dismukes WE; Avent CK; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jul; 20(1):88-97. PubMed ID: 6456688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia.
    Saito A
    Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.
    Platt R; Ehrlich SL; Afarian J; O'Brien TF; Pennington JE; Kass EH
    Antimicrob Agents Chemother; 1981 Sep; 20(3):351-5. PubMed ID: 6458233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
    Carbon C
    Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of moxalactam.
    Mathisen GE; Meyer RD; Thompson JM; Finegold SM
    Antimicrob Agents Chemother; 1982 May; 21(5):780-6. PubMed ID: 6213198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxalactam disodium (Moxam).
    Med Lett Drugs Ther; 1982 Feb; 24(602):13-4. PubMed ID: 6460163
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)].
    Terashima I; Nakamura A; Okimoto U; Sugaya N; Kurosaki T; Sato T; Iwata Y; Saito N; Uehara S
    Jpn J Antibiot; 1981 May; 34(5):747-56. PubMed ID: 6457173
    [No Abstract]   [Full Text] [Related]  

  • 13. Enterococcal infections in patients treated with moxalactam.
    Moellering RC
    Rev Infect Dis; 1982; 4 Suppl():S708-11. PubMed ID: 6218588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxalactam therapy vs. standard antimicrobial therapy for selected serious infections.
    Oblinger MJ; Bowers JT; Sande MA; Mandell GL
    Rev Infect Dis; 1982; 4 Suppl():S639-49. PubMed ID: 6218577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W; Pegram PS; McCall CE
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of moxalactam].
    Acar JF
    Sem Hop; 1983 Jun; 59(26):1990-3. PubMed ID: 6310793
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of lower respiratory tract infections with moxalactam.
    Lentino JR; Rytel MW; Moore E
    Antimicrob Agents Chemother; 1981 May; 19(5):801-6. PubMed ID: 6457557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moxalactam in complications of abdominal surgery].
    Dupeyron JP; Peter JD; Rigolot JC
    Sem Hop; 1983 Jun; 59(26):1985-9. PubMed ID: 6310792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam in pediatrics.
    Barson WJ; Nahata MC
    Drug Intell Clin Pharm; 1982 Feb; 16(2):113-4. PubMed ID: 6210520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.